Global Sickle Cell Disease Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sickle Cell Disease Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sickle Cell Disease Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sickle Cell Disease Drug by Country/Region, 2017, 2022 & 2028

2.2 Sickle Cell Disease Drug Segment by Type

2.2.1 ARQ-092

2.2.2 BIVV-003

2.2.3 CAL-H

2.2.4 CTX-001

2.2.5 DRX-194

2.2.6 Others

2.3 Sickle Cell Disease Drug Sales by Type

2.3.1 Global Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Sickle Cell Disease Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sickle Cell Disease Drug Sale Price by Type (2017-2022)

2.4 Sickle Cell Disease Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Sickle Cell Disease Drug Sales by Application

2.5.1 Global Sickle Cell Disease Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Sickle Cell Disease Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Sickle Cell Disease Drug Sale Price by Application (2017-2022)

3 Global Sickle Cell Disease Drug by Company

3.1 Global Sickle Cell Disease Drug Breakdown Data by Company

3.1.1 Global Sickle Cell Disease Drug Annual Sales by Company (2020-2022)

3.1.2 Global Sickle Cell Disease Drug Sales Market Share by Company (2020-2022)

3.2 Global Sickle Cell Disease Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Sickle Cell Disease Drug Revenue by Company (2020-2022)

3.2.2 Global Sickle Cell Disease Drug Revenue Market Share by Company (2020-2022)

3.3 Global Sickle Cell Disease Drug Sale Price by Company

3.4 Key Manufacturers Sickle Cell Disease Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sickle Cell Disease Drug Product Location Distribution

3.4.2 Players Sickle Cell Disease Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sickle Cell Disease Drug by Geographic Region

4.1 World Historic Sickle Cell Disease Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Sickle Cell Disease Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sickle Cell Disease Drug Annual Revenue by Geographic Region

4.2 World Historic Sickle Cell Disease Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Sickle Cell Disease Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sickle Cell Disease Drug Annual Revenue by Country/Region

4.3 Americas Sickle Cell Disease Drug Sales Growth

4.4 APAC Sickle Cell Disease Drug Sales Growth

4.5 Europe Sickle Cell Disease Drug Sales Growth

4.6 Middle East & Africa Sickle Cell Disease Drug Sales Growth

5 Americas

5.1 Americas Sickle Cell Disease Drug Sales by Country

5.1.1 Americas Sickle Cell Disease Drug Sales by Country (2017-2022)

5.1.2 Americas Sickle Cell Disease Drug Revenue by Country (2017-2022)

5.2 Americas Sickle Cell Disease Drug Sales by Type

5.3 Americas Sickle Cell Disease Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sickle Cell Disease Drug Sales by Region

6.1.1 APAC Sickle Cell Disease Drug Sales by Region (2017-2022)

6.1.2 APAC Sickle Cell Disease Drug Revenue by Region (2017-2022)

6.2 APAC Sickle Cell Disease Drug Sales by Type

6.3 APAC Sickle Cell Disease Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sickle Cell Disease Drug by Country

7.1.1 Europe Sickle Cell Disease Drug Sales by Country (2017-2022)

7.1.2 Europe Sickle Cell Disease Drug Revenue by Country (2017-2022)

7.2 Europe Sickle Cell Disease Drug Sales by Type

7.3 Europe Sickle Cell Disease Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sickle Cell Disease Drug by Country

8.1.1 Middle East & Africa Sickle Cell Disease Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Sickle Cell Disease Drug Sales by Type

8.3 Middle East & Africa Sickle Cell Disease Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug

10.3 Manufacturing Process Analysis of Sickle Cell Disease Drug

10.4 Industry Chain Structure of Sickle Cell Disease Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sickle Cell Disease Drug Distributors

11.3 Sickle Cell Disease Drug Customer

12 World Forecast Review for Sickle Cell Disease Drug by Geographic Region

12.1 Global Sickle Cell Disease Drug Market Size Forecast by Region

12.1.1 Global Sickle Cell Disease Drug Forecast by Region (2023-2028)

12.1.2 Global Sickle Cell Disease Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sickle Cell Disease Drug Forecast by Type

12.7 Global Sickle Cell Disease Drug Forecast by Application

13 Key Players Analysis

13.1 Acceleron Pharma Inc

13.1.1 Acceleron Pharma Inc Company Information

13.1.2 Acceleron Pharma Inc Sickle Cell Disease Drug Product Offered

13.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Acceleron Pharma Inc Main Business Overview

13.1.5 Acceleron Pharma Inc Latest Developments

13.2 Addmedica SAS

13.2.1 Addmedica SAS Company Information

13.2.2 Addmedica SAS Sickle Cell Disease Drug Product Offered

13.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Addmedica SAS Main Business Overview

13.2.5 Addmedica SAS Latest Developments

13.3 Angiocrine Bioscience Inc

13.3.1 Angiocrine Bioscience Inc Company Information

13.3.2 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Offered

13.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Angiocrine Bioscience Inc Main Business Overview

13.3.5 Angiocrine Bioscience Inc Latest Developments

13.4 Annexin Pharmaceuticals AB

13.4.1 Annexin Pharmaceuticals AB Company Information

13.4.2 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Offered

13.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Annexin Pharmaceuticals AB Main Business Overview

13.4.5 Annexin Pharmaceuticals AB Latest Developments

13.5 ArQule Inc

13.5.1 ArQule Inc Company Information

13.5.2 ArQule Inc Sickle Cell Disease Drug Product Offered

13.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 ArQule Inc Main Business Overview

13.5.5 ArQule Inc Latest Developments

13.6 Bio Products Laboratory Ltd

13.6.1 Bio Products Laboratory Ltd Company Information

13.6.2 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Offered

13.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bio Products Laboratory Ltd Main Business Overview

13.6.5 Bio Products Laboratory Ltd Latest Developments

13.7 Bioverativ Inc

13.7.1 Bioverativ Inc Company Information

13.7.2 Bioverativ Inc Sickle Cell Disease Drug Product Offered

13.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bioverativ Inc Main Business Overview

13.7.5 Bioverativ Inc Latest Developments

13.8 bluebird bio Inc

13.8.1 bluebird bio Inc Company Information

13.8.2 bluebird bio Inc Sickle Cell Disease Drug Product Offered

13.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 bluebird bio Inc Main Business Overview

13.8.5 bluebird bio Inc Latest Developments

13.9 Bristol-Myers Squibb Co

13.9.1 Bristol-Myers Squibb Co Company Information

13.9.2 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Offered

13.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bristol-Myers Squibb Co Main Business Overview

13.9.5 Bristol-Myers Squibb Co Latest Developments

13.10 Calimmune Inc

13.10.1 Calimmune Inc Company Information

13.10.2 Calimmune Inc Sickle Cell Disease Drug Product Offered

13.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Calimmune Inc Main Business Overview

13.10.5 Calimmune Inc Latest Developments

13.11 CRISPR Therapeutics

13.11.1 CRISPR Therapeutics Company Information

13.11.2 CRISPR Therapeutics Sickle Cell Disease Drug Product Offered

13.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 CRISPR Therapeutics Main Business Overview

13.11.5 CRISPR Therapeutics Latest Developments

13.12 CSL Ltd

13.12.1 CSL Ltd Company Information

13.12.2 CSL Ltd Sickle Cell Disease Drug Product Offered

13.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CSL Ltd Main Business Overview

13.12.5 CSL Ltd Latest Developments

13.13 Daiichi Sankyo Co Ltd

13.13.1 Daiichi Sankyo Co Ltd Company Information

13.13.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Offered

13.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Daiichi Sankyo Co Ltd Main Business Overview

13.13.5 Daiichi Sankyo Co Ltd Latest Developments

13.14 Editas Medicine Inc

13.14.1 Editas Medicine Inc Company Information

13.14.2 Editas Medicine Inc Sickle Cell Disease Drug Product Offered

13.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Editas Medicine Inc Main Business Overview

13.14.5 Editas Medicine Inc Latest Developments

13.15 Errant Gene Therapeutics LLC

13.15.1 Errant Gene Therapeutics LLC Company Information

13.15.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Offered

13.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Errant Gene Therapeutics LLC Main Business Overview

13.15.5 Errant Gene Therapeutics LLC Latest Developments

13.16 Gamida Cell Ltd

13.16.1 Gamida Cell Ltd Company Information

13.16.2 Gamida Cell Ltd Sickle Cell Disease Drug Product Offered

13.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Gamida Cell Ltd Main Business Overview

13.16.5 Gamida Cell Ltd Latest Developments

13.17 Genethon SA

13.17.1 Genethon SA Company Information

13.17.2 Genethon SA Sickle Cell Disease Drug Product Offered

13.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Genethon SA Main Business Overview

13.17.5 Genethon SA Latest Developments

13.18 Gilead Sciences Inc

13.18.1 Gilead Sciences Inc Company Information

13.18.2 Gilead Sciences Inc Sickle Cell Disease Drug Product Offered

13.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Gilead Sciences Inc Main Business Overview

13.18.5 Gilead Sciences Inc Latest Developments

13.19 Global Blood Therapeutics Inc

13.19.1 Global Blood Therapeutics Inc Company Information

13.19.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Offered

13.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Global Blood Therapeutics Inc Main Business Overview

13.19.5 Global Blood Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Sickle Cell Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sickle Cell Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ARQ-092

Table 4. Major Players of BIVV-003

Table 5. Major Players of CAL-H

Table 6. Major Players of CTX-001

Table 7. Major Players of DRX-194

Table 8. Major Players of Others

Table 9. Global Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

Table 11. Global Sickle Cell Disease Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global Sickle Cell Disease Drug Revenue Market Share by Type (2017-2022)

Table 13. Global Sickle Cell Disease Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Sickle Cell Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Table 16. Global Sickle Cell Disease Drug Revenue by Application (2017-2022)

Table 17. Global Sickle Cell Disease Drug Revenue Market Share by Application (2017-2022)

Table 18. Global Sickle Cell Disease Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Sickle Cell Disease Drug Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Sickle Cell Disease Drug Sales Market Share by Company (2020-2022)

Table 21. Global Sickle Cell Disease Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Sickle Cell Disease Drug Revenue Market Share by Company (2020-2022)

Table 23. Global Sickle Cell Disease Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Sickle Cell Disease Drug Producing Area Distribution and Sales Area

Table 25. Players Sickle Cell Disease Drug Products Offered

Table 26. Sickle Cell Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Sickle Cell Disease Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Sickle Cell Disease Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global Sickle Cell Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Sickle Cell Disease Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Sickle Cell Disease Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Sickle Cell Disease Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global Sickle Cell Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Sickle Cell Disease Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)

Table 39. Americas Sickle Cell Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

Table 43. Americas Sickle Cell Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Table 45. APAC Sickle Cell Disease Drug Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Sickle Cell Disease Drug Sales Market Share by Region (2017-2022)

Table 47. APAC Sickle Cell Disease Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Sickle Cell Disease Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

Table 51. APAC Sickle Cell Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Table 53. Europe Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)

Table 55. Europe Sickle Cell Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

Table 59. Europe Sickle Cell Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Sickle Cell Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Sickle Cell Disease Drug

Table 70. Key Market Challenges & Risks of Sickle Cell Disease Drug

Table 71. Key Industry Trends of Sickle Cell Disease Drug

Table 72. Sickle Cell Disease Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Sickle Cell Disease Drug Distributors List

Table 75. Sickle Cell Disease Drug Customer List

Table 76. Global Sickle Cell Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Sickle Cell Disease Drug Sales Market Forecast by Region

Table 78. Global Sickle Cell Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Sickle Cell Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Sickle Cell Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Sickle Cell Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Sickle Cell Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Sickle Cell Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Sickle Cell Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Sickle Cell Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Sickle Cell Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Sickle Cell Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Sickle Cell Disease Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Sickle Cell Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Sickle Cell Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Sickle Cell Disease Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Sickle Cell Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. Acceleron Pharma Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Acceleron Pharma Inc Sickle Cell Disease Drug Product Offered

Table 98. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Acceleron Pharma Inc Main Business

Table 100. Acceleron Pharma Inc Latest Developments

Table 101. Addmedica SAS Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. Addmedica SAS Sickle Cell Disease Drug Product Offered

Table 103. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Addmedica SAS Main Business

Table 105. Addmedica SAS Latest Developments

Table 106. Angiocrine Bioscience Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Offered

Table 108. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Angiocrine Bioscience Inc Main Business

Table 110. Angiocrine Bioscience Inc Latest Developments

Table 111. Annexin Pharmaceuticals AB Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Offered

Table 113. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Annexin Pharmaceuticals AB Main Business

Table 115. Annexin Pharmaceuticals AB Latest Developments

Table 116. ArQule Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. ArQule Inc Sickle Cell Disease Drug Product Offered

Table 118. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. ArQule Inc Main Business

Table 120. ArQule Inc Latest Developments

Table 121. Bio Products Laboratory Ltd Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Offered

Table 123. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Bio Products Laboratory Ltd Main Business

Table 125. Bio Products Laboratory Ltd Latest Developments

Table 126. Bioverativ Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. Bioverativ Inc Sickle Cell Disease Drug Product Offered

Table 128. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Bioverativ Inc Main Business

Table 130. Bioverativ Inc Latest Developments

Table 131. bluebird bio Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. bluebird bio Inc Sickle Cell Disease Drug Product Offered

Table 133. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. bluebird bio Inc Main Business

Table 135. bluebird bio Inc Latest Developments

Table 136. Bristol-Myers Squibb Co Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Offered

Table 138. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Bristol-Myers Squibb Co Main Business

Table 140. Bristol-Myers Squibb Co Latest Developments

Table 141. Calimmune Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Calimmune Inc Sickle Cell Disease Drug Product Offered

Table 143. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Calimmune Inc Main Business

Table 145. Calimmune Inc Latest Developments

Table 146. CRISPR Therapeutics Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 147. CRISPR Therapeutics Sickle Cell Disease Drug Product Offered

Table 148. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. CRISPR Therapeutics Main Business

Table 150. CRISPR Therapeutics Latest Developments

Table 151. CSL Ltd Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 152. CSL Ltd Sickle Cell Disease Drug Product Offered

Table 153. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. CSL Ltd Main Business

Table 155. CSL Ltd Latest Developments

Table 156. Daiichi Sankyo Co Ltd Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 157. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Offered

Table 158. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. Daiichi Sankyo Co Ltd Main Business

Table 160. Daiichi Sankyo Co Ltd Latest Developments

Table 161. Editas Medicine Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 162. Editas Medicine Inc Sickle Cell Disease Drug Product Offered

Table 163. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 164. Editas Medicine Inc Main Business

Table 165. Editas Medicine Inc Latest Developments

Table 166. Errant Gene Therapeutics LLC Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 167. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Offered

Table 168. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 169. Errant Gene Therapeutics LLC Main Business

Table 170. Errant Gene Therapeutics LLC Latest Developments

Table 171. Gamida Cell Ltd Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 172. Gamida Cell Ltd Sickle Cell Disease Drug Product Offered

Table 173. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 174. Gamida Cell Ltd Main Business

Table 175. Gamida Cell Ltd Latest Developments

Table 176. Genethon SA Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 177. Genethon SA Sickle Cell Disease Drug Product Offered

Table 178. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 179. Genethon SA Main Business

Table 180. Genethon SA Latest Developments

Table 181. Gilead Sciences Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 182. Gilead Sciences Inc Sickle Cell Disease Drug Product Offered

Table 183. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 184. Gilead Sciences Inc Main Business

Table 185. Gilead Sciences Inc Latest Developments

Table 186. Global Blood Therapeutics Inc Basic Information, Sickle Cell Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 187. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Offered

Table 188. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 189. Global Blood Therapeutics Inc Main Business

Table 190. Global Blood Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Sickle Cell Disease Drug

Figure 2. Sickle Cell Disease Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sickle Cell Disease Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Sickle Cell Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sickle Cell Disease Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ARQ-092

Figure 10. Product Picture of BIVV-003

Figure 11. Product Picture of CAL-H

Figure 12. Product Picture of CTX-001

Figure 13. Product Picture of DRX-194

Figure 14. Product Picture of Others

Figure 15. Global Sickle Cell Disease Drug Sales Market Share by Type in 2021

Figure 16. Global Sickle Cell Disease Drug Revenue Market Share by Type (2017-2022)

Figure 17. Sickle Cell Disease Drug Consumed in Hospital

Figure 18. Global Sickle Cell Disease Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 19. Sickle Cell Disease Drug Consumed in Clinic

Figure 20. Global Sickle Cell Disease Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 21. Sickle Cell Disease Drug Consumed in Others

Figure 22. Global Sickle Cell Disease Drug Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Sickle Cell Disease Drug Revenue Market Share by Application in 2021

Figure 25. Sickle Cell Disease Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Sickle Cell Disease Drug Revenue Market Share by Company in 2021

Figure 27. Global Sickle Cell Disease Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Sickle Cell Disease Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Sickle Cell Disease Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Sickle Cell Disease Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Sickle Cell Disease Drug Sales 2017-2022 (K Pcs)

Figure 32. Americas Sickle Cell Disease Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Sickle Cell Disease Drug Sales 2017-2022 (K Pcs)

Figure 34. APAC Sickle Cell Disease Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Sickle Cell Disease Drug Sales 2017-2022 (K Pcs)

Figure 36. Europe Sickle Cell Disease Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Sickle Cell Disease Drug Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Sickle Cell Disease Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Sickle Cell Disease Drug Sales Market Share by Country in 2021

Figure 40. Americas Sickle Cell Disease Drug Revenue Market Share by Country in 2021

Figure 41. United States Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Sickle Cell Disease Drug Sales Market Share by Region in 2021

Figure 46. APAC Sickle Cell Disease Drug Revenue Market Share by Regions in 2021

Figure 47. China Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Sickle Cell Disease Drug Sales Market Share by Country in 2021

Figure 54. Europe Sickle Cell Disease Drug Revenue Market Share by Country in 2021

Figure 55. Germany Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Sickle Cell Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug in 2021

Figure 68. Manufacturing Process Analysis of Sickle Cell Disease Drug

Figure 69. Industry Chain Structure of Sickle Cell Disease Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles